Wilson disease

References

Key articles

Askari FK, Greenson J, Dick RD, et al. Treatment of Wilson's disease with zinc. XVIII. initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med. 2003;142:385-390. Abstract

Nazer H, Ede RJ, Mowat AP, et al. Wilson's disease: clinical presentation and use of prognostic index. Gut. 1986;27:1377-1381. Abstract

Brewer GJ. Wilson's disease: a clinician's guide to recognition, diagnosis, and management. Boston, MA: Kluwer Academic Publishers, 2001.

Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LHJ, ed. Major problems in internal medicine. Vol 23. Philadelphia, PA: WB Saunders, 1984:1-171.

Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998;132:264-278. Abstract

Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol. 2006;63:521-527. Abstract

Reference articles

1. Bull PC, Thomas GR, Rommens JM, et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet. 1993;5:327-337. Abstract

2. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet. 1993;5:344-350. Abstract

3. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun. 1993;197:271-277. Abstract

4. Askari FK, Greenson J, Dick RD, et al. Treatment of Wilson's disease with zinc. XVIII. initial treatment of the hepatic decompensation presentation with trientine and zinc. J Lab Clin Med. 2003;142:385-390. Abstract

5. Nazer H, Ede RJ, Mowat AP, et al. Wilson's disease: clinical presentation and use of prognostic index. Gut. 1986;27:1377-1381. Abstract

6. Starosta-Rubinstein S, Young AB, Kluin K, et al. Clinical assessment of 31 patients with Wilson's disease: correlations with structural changes on magnetic resonance imaging. Arch Neurol. 1987;44:365-370. Abstract

7. Brewer GJ. Behavioral abnormalities in Wilson's disease. In: Weiner WJ, Lang AE, Anderson KE, eds. Behavioral neurology of movement disorders. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2005:262-274.

8. Brewer GJ. Wilson's disease: a clinician's guide to recognition, diagnosis, and management. Boston, MA: Kluwer Academic Publishers, 2001.

9. Hoogenraad TU. Wilson's disease. London, UK: Saunders, 1996.

10. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LHJ, ed. Major problems in internal medicine. Vol 23. Philadelphia, PA: WB Saunders, 1984:1-171.

11. Ala A, Borjigin J, Rochwarger A, et al. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005;41:668-670. Abstract

12. Cox DW, Roberts E. Wilson disease. Seattle: GeneClinics, University of Washington; 2006.Full text

13. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine Baltimore. 1992;71:139-164. Abstract

14. Brewer GJ, Yuzbasiyan-Gurkan V, Dick R, et al. Does a vegetarian diet control Wilson's disease? J Am Coll Nutr. 1993;12:527-530. Abstract

15. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med. 2000;223:39-46. Abstract

16. Brewer GJ. Wilson's disease. In: Kasper DL, Braunward E, Fauci AS, et al, eds. Harrison's principles of internal medicine. 16th ed. New York, NY: McGraw-Hill Companies, 2004:2313-2315.

17. Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Exp Opin Pharmacother. 2006;7:317-324. Abstract

18. Merle U, Eisenbach C, Weiss KH, et al. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease. J Hepatol. 2009;51:925-930. Abstract

19. McMillin GA, Travis JJ, Hunt JW. Direct measurement of free copper in serum or plasma ultrafiltrate. Am J Clin Pathol. 2009;131:160-165. Abstract

20. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089-2111.Full text  Abstract

21. Hedera P. Update on the clinical management of Wilson's disease. Appl Clin Genet. 2017 Jan 13;10:9-19.Full text  Abstract

22. Dhawan A, Taylor RM, Cheeseman P, et al. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl. 2005;11:441-448.Full text  Abstract

23. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 1982;1:643-647. Abstract

24. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998;132:264-278. Abstract

25. Walshe JM. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956;21:487-495. Abstract

26. Brewer GJ, Terry CA, Aisen AM, et al. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol. 1987;44:490-493. Abstract

27. Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol. 2006;63:521-527. Abstract

28. Brewer GJ, Hedera P, Kluin KJ, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol. 2003;60:379-385. Abstract

Use of this content is subject to our disclaimer